Marco Moschini

10.9k total citations · 1 hit paper
346 papers, 5.3k citations indexed

About

Marco Moschini is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Marco Moschini has authored 346 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 251 papers in Surgery, 123 papers in Pulmonary and Respiratory Medicine and 111 papers in Urology. Recurrent topics in Marco Moschini's work include Bladder and Urothelial Cancer Treatments (234 papers), Urinary and Genital Oncology Studies (179 papers) and Urological Disorders and Treatments (93 papers). Marco Moschini is often cited by papers focused on Bladder and Urothelial Cancer Treatments (234 papers), Urinary and Genital Oncology Studies (179 papers) and Urological Disorders and Treatments (93 papers). Marco Moschini collaborates with scholars based in Italy, United States and Austria. Marco Moschini's co-authors include Francesco Montorsi, Alberto Briganti, Shahrokh F. Shariat, Giorgio Gandaglia, Francesco Soria, Andrea Salonia, Paolo Dell’Oglio, Pierre I. Karakiewicz, Renzo Colombo and Agostino Mattei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Marco Moschini

321 papers receiving 5.3k citations

Hit Papers

Epidemiology, Screening, and Prevention of Bladder Cancer 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Moschini Italy 36 3.0k 2.4k 1.1k 966 676 346 5.3k
Ofer Yossepowitch Israel 35 1.8k 0.6× 3.4k 1.4× 740 0.7× 608 0.6× 848 1.3× 164 5.0k
Thierry Lebrét France 39 3.8k 1.3× 1.8k 0.7× 2.0k 1.9× 936 1.0× 574 0.8× 269 6.6k
Ganesh S. Palapattu United States 41 2.9k 1.0× 2.7k 1.1× 1.1k 1.0× 1.3k 1.3× 467 0.7× 185 6.5k
Simon Tanguay Canada 40 2.1k 0.7× 2.4k 1.0× 706 0.7× 816 0.8× 294 0.4× 213 4.7k
Gary D. Grossfeld United States 48 1.9k 0.6× 3.4k 1.4× 652 0.6× 1.4k 1.4× 820 1.2× 123 6.0k
Sima P. Porten United States 28 2.9k 1.0× 1.4k 0.6× 559 0.5× 1.2k 1.2× 208 0.3× 137 4.3k
J.C. Angulo Spain 34 1.8k 0.6× 1.6k 0.7× 2.0k 1.9× 730 0.8× 1.4k 2.0× 404 5.1k
S. Bruce Malkowicz United States 34 1.5k 0.5× 2.4k 1.0× 658 0.6× 697 0.7× 315 0.5× 132 4.4k
Luis Martínez‐Piñeiro Spain 26 2.3k 0.8× 741 0.3× 1.1k 1.0× 451 0.5× 277 0.4× 161 3.5k
Theresa M. Koppie United States 32 2.4k 0.8× 1.3k 0.5× 723 0.7× 909 0.9× 210 0.3× 71 4.2k

Countries citing papers authored by Marco Moschini

Since Specialization
Citations

This map shows the geographic impact of Marco Moschini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Moschini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Moschini more than expected).

Fields of papers citing papers by Marco Moschini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Moschini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Moschini. The network helps show where Marco Moschini may publish in the future.

Co-authorship network of co-authors of Marco Moschini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Moschini. A scholar is included among the top collaborators of Marco Moschini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Moschini. Marco Moschini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tateo, Valentina, Joep J. de Jong, Brigida Anna Maiorano, et al.. (2025). Impact of Molecular Androgen and Estrogen Response Scores on Outcomes Following Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 31(16). 3503–3511.
2.
3.
Angelis, Mario de, Andrea Baudo, Carolin Siech, et al.. (2024). The effect of race/ethnicity on cancer-specific mortality after trimodal therapy. Journal of Racial and Ethnic Health Disparities. 12(3). 1416–1422. 5 indexed citations
4.
Angelis, Mario de, Carolin Siech, Francesco Di Bello, et al.. (2024). Incidence, Characteristics and Survival Rates of Bladder Cancer after Rectosigmoid Cancer Radiation. Cancers. 16(13). 2404–2404. 2 indexed citations
5.
Longoni, Mattia, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.. (2024). Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer. British Journal of Urology. 135(5). 828–834. 1 indexed citations
6.
Pichler, Renate, Andrea Mari, Luca Afferi, et al.. (2024). Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid Instillations in Bladder Cancer. Journal of Clinical Medicine. 13(7). 2031–2031. 3 indexed citations
8.
Briganti, Alberto, Bradley C. Leibovich, Seth P. Lerner, et al.. (2023). Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023?. European Urology Oncology. 7(3). 412–420. 3 indexed citations
9.
Basile, Giuseppe, Marco Bandini, Ewan A. Gibb, et al.. (2022). Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial. Clinical Cancer Research. 28(23). 5107–5114. 64 indexed citations
11.
Bandini, Marco, Laura Marandino, Simone Scuderi, et al.. (2020). Outcome of non-responders to neoadjuvant immunotherapy compared to cisplatin-based chemotherapy before radical cystectomy in muscle-invasive bladder cancer. European Urology Open Science. 19. e1520–e1521.
12.
Foerster, Beat, Mohammad Abufaraj, Andrea Mari, et al.. (2020). The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC). Clinical Genitourinary Cancer. 19(3). 272.e1–272.e7. 11 indexed citations
13.
Zattoni, Fabio, Murat Gül, Matteo Soligo, et al.. (2020). The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends. International Journal of Impotence Research. 33(8). 824–831. 78 indexed citations
14.
Ahmed, Mohamed E., Giovanni Motterle, Jack R. Andrews, et al.. (2019). Salvage Radical Prostatectomy After Robot-assisted Laparoscopic Prostatectomy: Case Series. Clinical Genitourinary Cancer. 18(2). e202–e207.
15.
Kimura, Shoji, Francesco Soria, David D‘Andrea, et al.. (2018). Prognostic Value of Serum Cholinesterase in Non–muscle-invasive Bladder Cancer. Clinical Genitourinary Cancer. 16(6). e1123–e1132. 17 indexed citations
16.
Vartolomei, Mihai Dorin, David D‘Andrea, Daher Chade, et al.. (2018). Role of serum cholinesterase in patients treated with salvage radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 37(2). 123–129. 11 indexed citations
18.
Foerster, Beat, Marco Moschini, Mohammad Abufaraj, et al.. (2017). Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. Clinical Genitourinary Cancer. 15(6). e1039–e1045. 11 indexed citations
19.
Zaffuto, Emanuele, Raisa S. Pompe, Marc Zanaty, et al.. (2017). Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis. Clinical Genitourinary Cancer. 15(5). e793–e800. 60 indexed citations
20.
Moschini, Marco, Vidit Sharma, Giorgio Gandaglia, et al.. (2016). Long‐term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy. British Journal of Urology. 120(1). 69–75. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026